On Friday, Shares of Novartis AG (ADR)(NYSE:NVS), subtract -0.20% and closed at $78.29 in the last trading session. The last trading range of the stock ranges between $77.76 and $78.62. The company’s Market capitalization is $204.75 Billion with the total Outstanding Shares of 2.38Billion. During the 52-week trading session the minimum price at which share price traded, registered at $69.89 and reached to max level of $95.11. Novartis AG researches, develops, manufactures, and markets a range of healthcare products worldwide. It operates through three segments: Pharmaceuticals, Alcon, and Sandoz. The Pharmaceuticals segment offers patented prescription medicines for oncology, neuroscience, retina, immunology and dermatology, respiratory, cardio-metabolic, established medicines, and cell and gene therapies. The Alcon segment provides eye care products, counting ophthalmic surgical equipment, instruments, disposable products, and intraocular lenses; medicines to treat chronic and acute diseases of the eye, and over-the-counter medicines for the eye; and contact lenses and lens care products. The Sandoz segment offers generic prescription medicines that include active ingredients and finished dosage forms of pharmaceuticals for dermatology, respiratory and ophthalmic, cardiovascular, metabolism, central nervous system, pain, gastrointestinal, and hormonal therapies; active pharmaceutical ingredients and intermediates mainly antibiotics; protein or other biotechnology-based products; and cytotoxic products for the hospital markets, in addition to biotechnology manufacturing services to other companies.
Shares of Colony Capital Inc (NYSE:CLNY), subtract -1.55% and closed at $17.81 in the last trading session. The last trading range of the stock ranges between $17.80 and $18.26. The company’s Market capitalization is $1.99 Billion with the total Outstanding Shares of 113.79 Billion. During the 52-week trading session the minimum price at which share price traded, registered at $14.73 and reached to max level of $22.18. Colony Capital, Inc. is a real estate investment trust. The firm invests in the real estate markets of North America and Europe. Its investment portfolio is mainly composed of real estate equity; real estate and real estate-related debt; and investment administration of company-sponsored private equity funds and vehicles. The firm invests in wide spectrum of commercial real estate property types, counting but not limited to, office, industrial, retail, hospitality, education, single-family and multifamily residential assets, and geographies, mainly within North America and Europe.